Lymphocyte death in a mouse model of ebola virus infection

Journal of Infectious Diseases

Volumn 196, Issue SUPPL. 2, 2007, Pages

  Bradfute, Steven B ^a   Braun, Denise R ^a   Shamblin, Joshua D ^a   Geisbert, Joan B ^a   Paragas, Jason ^b   Garrison, Aura ^a   Hensley, Lisa E ^a   Geisbert, Thomas W ^b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; EBOLA VIRUS; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; GRANULOCYTOSIS; NATURAL KILLER CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; ANIMAL; ARTICLE; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE DEPLETION; MOUSE; PATHOLOGY; PRIMATE; T LYMPHOCYTE; VIRUS HEMORRHAGIC FEVER;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; DISEASE MODELS, ANIMAL; HEMORRHAGIC FEVER, EBOLA; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; LYMPHOCYTES; MICE; PRIMATES; T-LYMPHOCYTES;

EID: 38449094420     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520602     Document Type: Conference Paper

References (35)

1. Feldmann H, Geisbert TW, Jahrling PB, et al. Filoviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds. Virus taxonomy. Eighth report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press, 2004:645-53.
2. World Health Organization International Study Team. Ebola haemorrhagic fever in Sudan, 1976. Bull World Health Organ 1978; 56:247-70.
3. World Health Organization International Study Team. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978; 56:271-93.
4. Georges A-J, Leroy EM, Renaut AA, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis 1999; 179(Suppl 1):S65-75.
5. Khan AS, Kweteminga Tshioko F, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179(Suppl 1):S76-86.
6. Centers for Disease Control and Prevention. Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001. MMWR Morb Mortal Wkly Rep 2001; 50:73-7.
7. Bwaka MA, Bonnet M-J, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999; 179(Suppl 1):S1-7.
8. Feldmann H, Jones S, Klenk HD, Schnittler HJ. Ebola virus: from discovery to vaccine. Nat Rev Immunol 2003; 3:677-85.
9. Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med 2004;10(Suppl 12):S110-21.
10. Hensley LE, Jones SM, Feldmann H, Jahrling PB, Geisbert TW. Ebola and Marburg viruses: pathogenesis and development of countermeasures. Curr Mol Med 2005; 5:761-72.
11. Baize S, Leroy EM, Georges-Courbot MC, et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999; 5:423-6.
12. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000; 80:171-86.
13. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70.
14. Reed DS, Hensley LE, Geisbert JB, Jahrling PB, Geisbert TW. Depletion of peripheral blood T lymphocytes and NK cells during the course of Ebola hemorrhagic fever in cynomolgus macaques. Viral Immunol 2004; 17:390-400.
15. Zaki SR, Goldsmith CS. Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999; 235:97-116.
16. Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg Infect Dis 2002; 8:503-7.
17. + thymocyte depletion. Microb Pathog 2005; 39:189-96.
18. Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH. Quantitative pathology of inhalational anthrax. I. Quantitative microscopic findings. Mod Pathol 2001; 14:482-95.
19. Bruckner S, Rhamouni S, Tautz L, et al. Yersinia phosphatase induces mitochondrially dependent apoptosis of T cells. J Biol Chem 2005; 280:10388-94.
20. Ayala A, Herndon CD, Lehman DL, Ayala CA, Chaudry IH. Differential induction of apoptosis in lymphoid tissue during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 1996; 87:4261-75.
21. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-51.
22. + T lymphocytes in humans. J Immunol 2001; 166:6952-63.
23. Hotchkiss RS, Tinsley KW, Swanson PE, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999; 96:14541-6.
24. Ryabchikova E, Kolesnikova L, Smolina M, et al. Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch Virol 1996; 141:909-21.
25. Connolly BM, Steele KE, Davis KJ, et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 1999; 179(Suppl 1):S203-17.
26. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1998; 178:651-61.
27. Bray M, Hatfill S, Hensley L, Huggins JW. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 2001; 125:243-53.
28. Gibb TR, Bray M, Geisbert TW, et al. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 2001; 125:233-42.
29. Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animals Resources Commission of Life Sciences, National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
30. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57.
31. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001; 2:589-98.
32. Nicotera P, Leist M, Ferrando-May E. Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 1998; 102-3:139-42.
33. Oppenheim RW, Flavell RA, Vinsant S, Prevette D, Kuan CY, Rakic P. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J Neurosci 2001; 21:4752-60.
34. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16:663-9.
35. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003; 188:1618-29.